About Makronix Life Sciences
Makronix Life Sciences is a Healthcare company based in Vapi (India). Pharmaceutical products and distribution services in healthcare. Its Indian entity Makronix Life Sciences Private Limited reported revenue of ₹4.57 Cr. Makronix Life Sciences offers products and services including VILCETAM-SYRUP and Antihypertensives. Its focus areas include Nutraceuticals, Health Supplements, Product Distribution and Pharmaceuticals.
Company details
Makronix Life Sciences is identified as a pharmaceutical company that focuses on delivering quality healthcare at affordable costs, where product innovation is integrated with distribution strategies. Expertise from pharma professionals and medical visionaries is brought together to enhance patient care through accessible medical solutions and global market presence. A strong emphasis is placed on promoting wellness by addressing needs in antihypertensives, analgesics, and other categories, ensuring effective mechanisms for worldwide accessibility.
- Headquarters Vapi, India
- SectorsHealthcare
- Email••••••••
- Website makronixlifesciences.com
- Social LinkedIn X Facebook
- Legal Name Makronix Life Sciences Private Limited
- Date of Incorporation 09 Dec, 2016
- Jurisdiction Vapi, Gujarat, India
- Annual Revenue₹4.57 Cr
FY 2024 · +101% YoY
- Net Profit₹1.8 Lakh
FY 2024 · 0% margin
- EBITDA₹4.1 Lakh
FY 2024 · 1% margin
Associated legal entities of Makronix Life Sciences
Makronix Life Sciences operates through Makronix Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Makronix Life Sciences Private Limited CIN U74999GJ2016PTC094653 | Active | 09 Dec 2016 | Vapi, Gujarat | ₹4.6 Cr | 4 | View details |
Products & Services of Makronix Life Sciences
Makronix Life Sciences offers a comprehensive portfolio of products and services, including VILCETAM-SYRUP and Antihypertensives.
A syrup that is utilized for nootropic purposes and is featured in the product gallery of Makronix Life Sciences.
Drugs that are designed for the management of high blood pressure and are listed among the offerings of Makronix Life Sciences.
Board of directors of Makronix Life Sciences Private Limited (Makronix Life Sciences)
Makronix Life Sciences Private Limited is the primary company behind Makronix Life Sciences. The board of Makronix Life Sciences Private Limited currently have 4 directors; the longest-serving is Silla Praveen Kumar Patro, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Silla Praveen Kumar Patro DIN 07633808 | Director | 09 Dec 2016 | 9 yrs 11 mo | Makronix Life Sciences Private Limited |
| Aurobinda Singh DIN 07633814 | Director | 09 Dec 2016 | 9 yrs 11 mo | Makronix Life Sciences Private Limited |
| Asadi Chandrasekhar Patra DIN 07633828 | Director | 09 Dec 2016 | 9 yrs 11 mo | Makronix Life Sciences Private Limited |
| Sudipta Narayan Patra DIN 07633829 | Director | 09 Dec 2016 | 9 yrs 11 mo | Makronix Life Sciences Private Limited |
Financials of Makronix Life Sciences
Figures of Makronix Life Sciences Private Limited, the primary company behind Makronix Life Sciences, for FY 2024. Revenue was ₹4.57 Cr (+101% year on year). Net profit was ₹1.8 Lakh (0% margin). EBITDA was ₹4.1 Lakh (1% margin). Revenue has grown at a compounded annual rate of +71% over three years and +55% over five years.
- ₹4.57 CrRevenue · FY 2024 · +101% YoY
- ₹1.8 LakhNet profit · 0% margin
- ₹4.1 LakhEBITDA · 1% margin
- ₹10 LakhPaid-up capital
- +71%Revenue CAGR, 3 years
- +55%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Makronix Life Sciences Private Limited are on its company page.
Detailed financial statements for Makronix Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Makronix Life Sciences
Makronix Life Sciences is headquartered in Vapi, India. It is registered at Vapi, Gujarat, India.
The primary company behind Makronix Life Sciences, Makronix Life Sciences Private Limited, reported revenue of ₹4.57 Cr for FY 2024, up 101% year on year.
Makronix Life Sciences is identified as a pharmaceutical company that focuses on delivering quality healthcare at affordable costs, where product innovation is integrated with distribution strategies. Expertise from pharma professionals and medical visionaries is brought together to enhance patient care through accessible medical solutions and global market presence. A strong emphasis is placed on promoting wellness by addressing needs in antihypertensives, analgesics, and other categories, ensuring effective mechanisms for worldwide accessibility.
Makronix Life Sciences offers VILCETAM-SYRUP and Antihypertensives.
Makronix Life Sciences operates through Makronix Life Sciences Private Limited.
The legal entities of Makronix Life Sciences currently have 4 directors, including Silla Praveen Kumar Patro, Aurobinda Singh, Asadi Chandrasekhar Patra and others.